Profile | GDS4284 / 230452_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 171.818 | 47 |
GSM687648 | Patient 402 control | 231.082 | 52 |
GSM687653 | Patient 403 control | 239.674 | 53 |
GSM687658 | Patient 404 control | 224.311 | 50 |
GSM687663 | Patient 411 control | 258.64 | 52 |
GSM687668 | Patient 422 control | 211.158 | 50 |
GSM687673 | Patient 424 control | 260.135 | 52 |
GSM687678 | Patient 425 control | 225.892 | 49 |
GSM687683 | Patient 427 control | 318.666 | 55 |
GSM687688 | Patient 428 control | 256.054 | 53 |
GSM687695 | Patient 441 control | 408.228 | 57 |
GSM687699 | Patient 443 control | 550.861 | 64 |
GSM687704 | Patient 444 control | 154.229 | 43 |
GSM687707 | Patient 448 control | 285.274 | 53 |
GSM687712 | Patient 449 control | 220.475 | 50 |
GSM687719 | Patient 450 control | 441.882 | 60 |
GSM687724 | Patient 451 control | 155.416 | 40 |
GSM687728 | Patient 452 control | 158.383 | 42 |
GSM687646 | Patient 401 treated 24h | 219.314 | 50 |
GSM687649 | Patient 402 treated 24h | 362.701 | 59 |
GSM687665 | Patient 411 treated 24h | 347.823 | 57 |
GSM687651 | Patient 402 treated 4 weeks | 376.996 | 59 |
GSM687667 | Patient 411 treated 4 weeks | 155.469 | 43 |
GSM687670 | Patient 422 treated 24h | 183.111 | 45 |
GSM687671 | Patient 422 treated 4 weeks | 242.654 | 52 |
GSM687654 | Patient 403 treated 24h | 52.1518 | 25 |
GSM687675 | Patient 424 treated 24h | 184.234 | 45 |
GSM687685 | Patient 427 treated 24h | 253.975 | 52 |
GSM687656 | Patient 403 treated 4 weeks | 259.163 | 55 |
GSM687677 | Patient 424 treated 4 weeks | 150.292 | 43 |
GSM687687 | Patient 427 treated 4 weeks | 165.327 | 46 |
GSM687692 | Patient 428 treated 4h | 309.894 | 56 |
GSM687716 | Patient 449 treated 4h | 321.878 | 58 |
GSM687722 | Patient 450 treated 4h | 377.334 | 58 |
GSM687680 | Patient 425 treated 24h | 190.545 | 47 |
GSM687690 | Patient 428 treated 24h | 300.957 | 57 |
GSM687700 | Patient 443 treated 24h | 365.989 | 54 |
GSM687705 | Patient 444 treated 24h | 172.552 | 47 |
GSM687714 | Patient 449 treated 24h | 174.332 | 47 |
GSM687721 | Patient 450 treated 24h | 353.054 | 56 |
GSM687682 | Patient 425 treated 4 weeks | 250.577 | 53 |
GSM687694 | Patient 428 treated 4 weeks | 285.942 | 56 |
GSM687702 | Patient 443 treated 4 weeks | 257.473 | 51 |
GSM687718 | Patient 449 treated 4 weeks | 302.805 | 56 |
GSM687723 | Patient 450 treated 4 weeks | 335.552 | 57 |
GSM687661 | Patient 404 treated 4h | 362.117 | 58 |
GSM687710 | Patient 448 treated 4h | 183.204 | 47 |
GSM687726 | Patient 451 treated 4h | 196.682 | 45 |
GSM687730 | Patient 452 treated 4h | 853.314 | 70 |
GSM687660 | Patient 404 treated 24h | 295.308 | 53 |
GSM687697 | Patient 441 treated 24h | 458.176 | 60 |
GSM687709 | Patient 448 treated 24h | 64.7818 | 25 |
GSM687725 | Patient 451 treated 24h | 348.34 | 56 |
GSM687729 | Patient 452 treated 24h | 429.816 | 60 |
GSM687727 | Patient 451 treated 4 weeks | 104.539 | 31 |
GSM687731 | Patient 452 treated 4 weeks | 228.058 | 49 |